WO2023144750 - COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTIONS
National phase entry:
Publication Number
WO/2023/144750
Publication Date
03.08.2023
International Application No.
PCT/IB2023/050687
International Filing Date
26.01.2023
Title **
[English]
COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTIONS
[French]
POLYTHÉRAPIE POUR LE TRAITEMENT D'INFECTIONS PAR LE VIRUS DE L'HÉPATITE B
Applicants **
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Inventors
DELAHAYE, Jared Loren
LEIVERS, Martin R.
OKOUR, Malek
YOU, Shihyun Kieffer
Priority Data
63/304,091
28.01.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2195 | |
| EPO | Filing, Examination, Granting | 9685 | |
| Japan | Filing, Examination, Granting | 2232 | |
| South Korea | Filing, Examination, Granting | 2174 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
22,226
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure is related to methods for treating hepatitis B infections. The methods comprising administering a subject in need thereof a PAPD5/7 inhibitor and a modified ASO that targets HBV mRNAs.[French]
La présente invention concerne des méthodes de traitement d'infections par l'hépatite B. Les méthodes consistent à administrer, à un sujet en ayant besoin, un inhibiteur de PAPD5/7 et un ASO modifié qui cible les ARNm du VHB.